OWC Pharmaceutical Research Corp. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced net income was USD 7.707 million compared to net loss of USD 3.209 million a year ago. Basic earnings per share from continuing operations was USD 0.04 compared to basic loss per share from continuing operations of USD 0.03 a year ago. Diluted eps - continuing operations was USD 0 compared to diluted loss per share from continuing operations of USD 0.03 a year ago. For the half year, net income was USD 6.707 million compared to net loss of USD 4.186 million a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to basic loss per share from continuing operations of USD 0.03 a year ago. Diluted eps - continuing operations was USD 0 compared to diluted loss per share from continuing operations of USD 0.03 a year ago.